Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

GE Healthcare Ireland Limited recalls GE Healthcare Omnipaque (iohexol) Injection

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
Presence of particulate matter
Products
  • GE Healthcare Omnipaque (iohexol) Injection
Where it was sold

U.S. Nationwide.

Nationwide

Units affected
866,570 vials
About this recall
GE Healthcare Omnipaque (iohexol) Injection, 300 mg/mL (64.7%), Rx Only, Distributed by: GE Healthcare Inc., Marlborough, MA 01752 USA, NDC 0407-1413-63.